Moderna names Michael R. McDonnell as director insider

Moderna, Inc. filed an initial statement of beneficial ownership for Michael R. McDonnell, identifying him as a director of the company.

Rhea-AI Filing Summary

Moderna, Inc. filed an initial statement of beneficial ownership for Michael R. McDonnell, identifying him as a director of the company. The filing does not report any equity transactions or derivative positions and serves to register his status as a reporting person with the SEC.

Key Terms

reporting person, director, ten percent owner

3 terms

reporting person regulatory

"The filing identifies Michael R. McDonnell as a reporting person."

director regulatory

"The Form 3 designates Michael R. McDonnell as a director of Moderna, Inc."

ten percent owner regulatory

"The ten percent owner status for Michael R. McDonnell is marked as not applicable."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Moderna (MRNA) disclose about Michael R. McDonnell in this Form 3?

The Form 3 identifies Michael R. McDonnell as a director of Moderna, Inc.. It is an initial statement of beneficial ownership and does not list any equity transactions.

Does the Moderna (MRNA) Form 3 for Michael R. McDonnell show any stock trades?

No stock trades are shown. The Form 3 for Michael R. McDonnell reports no transactions and functions solely as an initial beneficial ownership statement for a company director.

Is Michael R. McDonnell reported as a ten percent owner in Moderna (MRNA)?

Michael R. McDonnell is not reported as a ten percent owner. The Form 3 shows him as a director only, with the ten percent owner status marked as not applicable.

Does the Moderna (MRNA) Form 3 indicate Michael R. McDonnell is an officer?

The filing does not identify Michael R. McDonnell as an officer. It marks him as a director and indicates no officer title in the officer fields.

What is the significance of a Form 3 filing like this for Moderna (MRNA)?

A Form 3 establishes an insider, such as a director, as a reporting person for SEC purposes. For Moderna, this filing registers Michael R. McDonnell’s reporting status without disclosing any trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/10/2026 - 05:05 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

McDonnell Michael R.

(Last) (First) (Middle)

C/O MODERNA, INC.

325 BINNEY STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/08/2026

3. Issuer Name and Ticker or Trading Symbol
Moderna, Inc. [ MRNA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ James Dillon, as Attorney-in-Fact	07/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)